跳至主要内容
临床试验/NCT04567953
NCT04567953Unknown不适用

COVID-19 Tests With Saliva Specimens

Paradigm Laboratories LLC2 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2020年7月28日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
2,000
试验地点
2
主要终点
The clinical evaluation of saliva as specimen for COVID-19 molecular test

研究概览

简要总结

Upper respiratory swabs, such as the nasopharyngeal (NP) swab, have so far been major specimen sources used for the SARS-COV-2 molecular test. However, due to the discomfort and invasiveness of NP collection, and the expense of personal protective equipment, alternative sampling sources such as saliva are desired. The purpose of this proposed study is: 1) to examine whether saliva can be used as an specimen for the SARS-COV-2 molecular test; 2) to test if gingival crevicular fluids is a reliable specimen for the SARS-COV-2 antibodies.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Persons referred for COVID-19 testing including those with COVID-19 symptoms and/or a suspected SARS-COV-2 infection or undergoing surveillance testing and
  • Is able to give informed consent
  • Is able to understand oral or written instructions, and
  • Is able to mentally and physically perform self-collection of saliva using the provided collection device.

排除标准

  • - Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Employees of Paradigm lab and the assisted living facilities involved in the study
  • Members of other vulnerable populations

结局指标

主要结局

The clinical evaluation of saliva as specimen for COVID-19 molecular test

时间窗: 1 hour

We will evaluate the positive and negative agreement of saliva with nasopharyngeal swab as specimens for COVID-19 molecular test.

次要结局

未报告次要终点

研究者

发起方
Paradigm Laboratories LLC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

COVID-19 Tests With Saliva Specimens | 临床试验